WILMINGTON, Del., June 1, 2022
/PRNewswire/ -- DuPont (NYSE: DD) today announced completion of the
previously-announced sale of its Biomaterials business unit,
effective May 31, 2022, to the Huafon
Group for a purchase price of approximately $240 million.
The results of operations of the Biomaterials business unit were
previously reported in Corporate & Other. For full year 2021,
the Biomaterials business unit recorded net sales of approximately
$200 million.
About DuPont
DuPont (NYSE: DD) is a global innovation
leader with technology-based materials and solutions that help
transform industries and everyday life. Our employees apply diverse
science and expertise to help customers advance their best ideas
and deliver essential innovations in key markets including
electronics, transportation, construction, water, healthcare and
worker safety. More information about the company, its businesses
and solutions can be found at www.dupont.com. Investors can
access information included on the Investor Relations section of
the website at investors.dupont.com.
About the Huafon Group
Founded in 1991 and
headquartered in Ruian, China, the
Huafon Group has been innovating to provide new material solutions
globally in multiple industries by promoting sustainability,
safety, technology and quality. Huafon Group is one of the largest
manufacturers of polyurethane (PU) materials in the world with
broad product portfolio in adipic acid, polyester polyols, spandex
filament, microfiber material, TPU, polyamide etc. Huafon Group has
more than 14,000 employees and owns multiple subsidiary companies
globally in chemical, metals, finance, logistics, information
technology and trade.
DuPont™ and all products, unless otherwise noted, denoted with
™, SM or ® are trademarks, service marks or
registered trademarks of affiliates of DuPont de Nemours, Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dupont-completes-divestiture-of-biomaterials-business-301558537.html
SOURCE DuPont